Related Experiment Video

Updated: Apr 15, 2026

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

1.3K

Neonatal hypoglycemia screening in newborns from diabetic mothers--arguments and controversies

A Stanescu1, S M Stoicescu2

  • 1"Dr. I. Cantacuzino" Clinical Hospital, Bucharest, Romania.

Journal of Medicine and Life
|April 15, 2015
PubMed

Insights

Newborns of diabetic mothers face a high risk of postnatal hypoglycemia, a serious complication that can lead to severe neurological issues or death. Early screening and management are crucial for this vulnerable population.

Area of Science:

  • Neonatal Medicine
  • Endocrinology
  • Pediatrics

Background:

  • Infants born to mothers with diabetes (type 1, type 2, or gestational) are at increased risk for metabolic complications.
  • Postnatal hypoglycemia is a significant and potentially life-threatening metabolic complication in these newborns.

Purpose of the Study:

  • To highlight the critical importance of screening for postnatal hypoglycemia in newborns of diabetic mothers.
  • To discuss current management strategies and ongoing debates regarding this condition.

Main Methods:

  • Review of existing literature and clinical guidelines.
  • Analysis of the risks associated with undiagnosed hypoglycemia in this high-risk group.

Main Results:

  • Undiagnosed hypoglycemia in newborns of diabetic mothers carries a significantly higher risk of severe neurological damage and mortality compared to the general population.
  • Early identification and intervention are paramount to prevent adverse outcomes.

Conclusions:

  • Screening for postnatal hypoglycemia in the early hours after birth is essential for all infants of diabetic mothers.
  • Further research and consensus are needed to address debated management topics.

Keywords:
maternal diabetesneonatal hypoglycemianeonatal screeningnewborn

More Related Videos

Biochemical Measurement of Neonatal Hypoxia13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.5K
Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
6.9K